Sevelamer crystals in the gastrointestinal tract (GIT)

A new entity associated with mucosal injury

Benjamin J Swanson, Berkeley N. Limketkai, Ta Chiang Liu, Elizabeth Montgomery, Kamran Nazari, Jason Y. Park, William C. Santangelo, Michael S. Torbenson, Lysandra Voltaggio, Martha M. Yearsley, Christina A. Arnold

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

We report the first description of sevelamer crystals (Renagel and Renvela, Genzyme; phosphate-lowering agents) in the gastrointestinal tract. We prospectively collected cases with novel, histologically identical crystals from 4 major academic centers over a 1-year period and studied pertinent clinicopathologic features. Sevelamer usage in the setting of chronic kidney disease was demonstrated in all cases (n=15 total cases, 7 patients). Sites of involvement included the esophagus (n=2), small bowel (n=2), and colon (n=11). The background mucosa was normal in only 1 case. Notable mucosal abnormality included chronic mucosal damage (n=5), acute inflammation (n=4), inflammatory polyp (n=2), extensive ulceration (n=2), ischemia (n=1), and necrosis (n=1). In general, sevelamer crystals displayed broad, curved, and irregularly spaced "fish scales" with a variably eosinophilic to rusty brown color on hematoxylin and eosin (H&E) staining and violet color on periodic acid-Schiff-Alcian special staining with diastase (PAS/D). To validate these findings, sevelamer tablets (Renvela) were crushed and submitted for histologic processing; the findings were identical to those in the patient specimens. The possibility of Kayexalate (sodium polystyrene sulfonate) and cholestyramine had been raised in error. However, Kayexalate has narrow, rectangular "fish scales" and is violet on H&E and magenta on PAS/D; cholestyramine lacks internal "fish scales," is bright orange on H&E, variably gray or hot pink on PAS/D, and is unassociated with mucosal injury. Further study is required to determine whether sevelamer plays a causal role in these injuries; however, its crystal is an important mimic of both Kayexalate and choleystyramine. As the history of sevelamer administration was not documented in any pathology requisition, awareness of sevelamer's characteristic morphology is crucial to avoid the diagnostic pitfalls of its mimics.

Original languageEnglish (US)
Pages (from-to)1686-1693
Number of pages8
JournalAmerican Journal of Surgical Pathology
Volume37
Issue number11
DOIs
StatePublished - Nov 1 2013

Fingerprint

Gastrointestinal Tract
Wounds and Injuries
Cholestyramine Resin
Fishes
Color
Staining and Labeling
Periodic Acid
Sevelamer
Hematoxylin
Amylases
Eosine Yellowish-(YS)
Polyps
Chronic Renal Insufficiency
Esophagus
Tablets
Colon
Mucous Membrane
Necrosis
Ischemia
History

Keywords

  • Kayexalate
  • Renagel
  • Renvela
  • cholestyramine
  • chronic kidney disease
  • crystal
  • ion-exchange resin
  • phosphate
  • sevelamer carbonate
  • sevelamer hydrochloride

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Sevelamer crystals in the gastrointestinal tract (GIT) : A new entity associated with mucosal injury. / Swanson, Benjamin J; Limketkai, Berkeley N.; Liu, Ta Chiang; Montgomery, Elizabeth; Nazari, Kamran; Park, Jason Y.; Santangelo, William C.; Torbenson, Michael S.; Voltaggio, Lysandra; Yearsley, Martha M.; Arnold, Christina A.

In: American Journal of Surgical Pathology, Vol. 37, No. 11, 01.11.2013, p. 1686-1693.

Research output: Contribution to journalArticle

Swanson, BJ, Limketkai, BN, Liu, TC, Montgomery, E, Nazari, K, Park, JY, Santangelo, WC, Torbenson, MS, Voltaggio, L, Yearsley, MM & Arnold, CA 2013, 'Sevelamer crystals in the gastrointestinal tract (GIT): A new entity associated with mucosal injury', American Journal of Surgical Pathology, vol. 37, no. 11, pp. 1686-1693. https://doi.org/10.1097/PAS.0b013e3182999d8d
Swanson, Benjamin J ; Limketkai, Berkeley N. ; Liu, Ta Chiang ; Montgomery, Elizabeth ; Nazari, Kamran ; Park, Jason Y. ; Santangelo, William C. ; Torbenson, Michael S. ; Voltaggio, Lysandra ; Yearsley, Martha M. ; Arnold, Christina A. / Sevelamer crystals in the gastrointestinal tract (GIT) : A new entity associated with mucosal injury. In: American Journal of Surgical Pathology. 2013 ; Vol. 37, No. 11. pp. 1686-1693.
@article{22e84bd43e214869b40b531383bdc81d,
title = "Sevelamer crystals in the gastrointestinal tract (GIT): A new entity associated with mucosal injury",
abstract = "We report the first description of sevelamer crystals (Renagel and Renvela, Genzyme; phosphate-lowering agents) in the gastrointestinal tract. We prospectively collected cases with novel, histologically identical crystals from 4 major academic centers over a 1-year period and studied pertinent clinicopathologic features. Sevelamer usage in the setting of chronic kidney disease was demonstrated in all cases (n=15 total cases, 7 patients). Sites of involvement included the esophagus (n=2), small bowel (n=2), and colon (n=11). The background mucosa was normal in only 1 case. Notable mucosal abnormality included chronic mucosal damage (n=5), acute inflammation (n=4), inflammatory polyp (n=2), extensive ulceration (n=2), ischemia (n=1), and necrosis (n=1). In general, sevelamer crystals displayed broad, curved, and irregularly spaced {"}fish scales{"} with a variably eosinophilic to rusty brown color on hematoxylin and eosin (H&E) staining and violet color on periodic acid-Schiff-Alcian special staining with diastase (PAS/D). To validate these findings, sevelamer tablets (Renvela) were crushed and submitted for histologic processing; the findings were identical to those in the patient specimens. The possibility of Kayexalate (sodium polystyrene sulfonate) and cholestyramine had been raised in error. However, Kayexalate has narrow, rectangular {"}fish scales{"} and is violet on H&E and magenta on PAS/D; cholestyramine lacks internal {"}fish scales,{"} is bright orange on H&E, variably gray or hot pink on PAS/D, and is unassociated with mucosal injury. Further study is required to determine whether sevelamer plays a causal role in these injuries; however, its crystal is an important mimic of both Kayexalate and choleystyramine. As the history of sevelamer administration was not documented in any pathology requisition, awareness of sevelamer's characteristic morphology is crucial to avoid the diagnostic pitfalls of its mimics.",
keywords = "Kayexalate, Renagel, Renvela, cholestyramine, chronic kidney disease, crystal, ion-exchange resin, phosphate, sevelamer carbonate, sevelamer hydrochloride",
author = "Swanson, {Benjamin J} and Limketkai, {Berkeley N.} and Liu, {Ta Chiang} and Elizabeth Montgomery and Kamran Nazari and Park, {Jason Y.} and Santangelo, {William C.} and Torbenson, {Michael S.} and Lysandra Voltaggio and Yearsley, {Martha M.} and Arnold, {Christina A.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1097/PAS.0b013e3182999d8d",
language = "English (US)",
volume = "37",
pages = "1686--1693",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Sevelamer crystals in the gastrointestinal tract (GIT)

T2 - A new entity associated with mucosal injury

AU - Swanson, Benjamin J

AU - Limketkai, Berkeley N.

AU - Liu, Ta Chiang

AU - Montgomery, Elizabeth

AU - Nazari, Kamran

AU - Park, Jason Y.

AU - Santangelo, William C.

AU - Torbenson, Michael S.

AU - Voltaggio, Lysandra

AU - Yearsley, Martha M.

AU - Arnold, Christina A.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - We report the first description of sevelamer crystals (Renagel and Renvela, Genzyme; phosphate-lowering agents) in the gastrointestinal tract. We prospectively collected cases with novel, histologically identical crystals from 4 major academic centers over a 1-year period and studied pertinent clinicopathologic features. Sevelamer usage in the setting of chronic kidney disease was demonstrated in all cases (n=15 total cases, 7 patients). Sites of involvement included the esophagus (n=2), small bowel (n=2), and colon (n=11). The background mucosa was normal in only 1 case. Notable mucosal abnormality included chronic mucosal damage (n=5), acute inflammation (n=4), inflammatory polyp (n=2), extensive ulceration (n=2), ischemia (n=1), and necrosis (n=1). In general, sevelamer crystals displayed broad, curved, and irregularly spaced "fish scales" with a variably eosinophilic to rusty brown color on hematoxylin and eosin (H&E) staining and violet color on periodic acid-Schiff-Alcian special staining with diastase (PAS/D). To validate these findings, sevelamer tablets (Renvela) were crushed and submitted for histologic processing; the findings were identical to those in the patient specimens. The possibility of Kayexalate (sodium polystyrene sulfonate) and cholestyramine had been raised in error. However, Kayexalate has narrow, rectangular "fish scales" and is violet on H&E and magenta on PAS/D; cholestyramine lacks internal "fish scales," is bright orange on H&E, variably gray or hot pink on PAS/D, and is unassociated with mucosal injury. Further study is required to determine whether sevelamer plays a causal role in these injuries; however, its crystal is an important mimic of both Kayexalate and choleystyramine. As the history of sevelamer administration was not documented in any pathology requisition, awareness of sevelamer's characteristic morphology is crucial to avoid the diagnostic pitfalls of its mimics.

AB - We report the first description of sevelamer crystals (Renagel and Renvela, Genzyme; phosphate-lowering agents) in the gastrointestinal tract. We prospectively collected cases with novel, histologically identical crystals from 4 major academic centers over a 1-year period and studied pertinent clinicopathologic features. Sevelamer usage in the setting of chronic kidney disease was demonstrated in all cases (n=15 total cases, 7 patients). Sites of involvement included the esophagus (n=2), small bowel (n=2), and colon (n=11). The background mucosa was normal in only 1 case. Notable mucosal abnormality included chronic mucosal damage (n=5), acute inflammation (n=4), inflammatory polyp (n=2), extensive ulceration (n=2), ischemia (n=1), and necrosis (n=1). In general, sevelamer crystals displayed broad, curved, and irregularly spaced "fish scales" with a variably eosinophilic to rusty brown color on hematoxylin and eosin (H&E) staining and violet color on periodic acid-Schiff-Alcian special staining with diastase (PAS/D). To validate these findings, sevelamer tablets (Renvela) were crushed and submitted for histologic processing; the findings were identical to those in the patient specimens. The possibility of Kayexalate (sodium polystyrene sulfonate) and cholestyramine had been raised in error. However, Kayexalate has narrow, rectangular "fish scales" and is violet on H&E and magenta on PAS/D; cholestyramine lacks internal "fish scales," is bright orange on H&E, variably gray or hot pink on PAS/D, and is unassociated with mucosal injury. Further study is required to determine whether sevelamer plays a causal role in these injuries; however, its crystal is an important mimic of both Kayexalate and choleystyramine. As the history of sevelamer administration was not documented in any pathology requisition, awareness of sevelamer's characteristic morphology is crucial to avoid the diagnostic pitfalls of its mimics.

KW - Kayexalate

KW - Renagel

KW - Renvela

KW - cholestyramine

KW - chronic kidney disease

KW - crystal

KW - ion-exchange resin

KW - phosphate

KW - sevelamer carbonate

KW - sevelamer hydrochloride

UR - http://www.scopus.com/inward/record.url?scp=84886444340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886444340&partnerID=8YFLogxK

U2 - 10.1097/PAS.0b013e3182999d8d

DO - 10.1097/PAS.0b013e3182999d8d

M3 - Article

VL - 37

SP - 1686

EP - 1693

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 11

ER -